Health Check: Vitrafy addresses looming US platelet shortage with US blood bank collab

In response to a “looming crisis” in red blood cell preservation, cryogenics play Vitrafy Life Sciences (ASX:VFY) has ...

[Ad hoc announcement pursuant to Art. 53 LR] Roche’s strong momentum continues in the first half of 2026, delivering +6% sales growth at constant exchange rates; -2…

Group sales were +6% at constant exchange rates (CER)1, -2% when reported in CHF and +8% in USD2, in the first six months, ...